Onyx Biotec IPO: Is the 11% Discount a Sign of Trouble? Exploring the Latest GMP Insights!
Introduction to Onyx Biotec IPO The financial world is buzzing with the recent debut of Onyx Biotec’s IPO, which has brought a mix of excitement and skepticism among investors. As shares of Onyx Biotec made their entry onto the NSE SME platform, they opened at an 11% discount, raising eyebrows and igniting discussions about the ...




